References
Shorrock CJ, Garner A. Drug News and Perspectives 4: 279–287, 1991
Jensen DM. Am J Med 81 (Suppl. 4B): 42–48, 1986
Glise H. Scand J Gastroenterol 25 (Suppl. 175): 13–18, 1990
Taylor T, Milne T. Inpharma No. 837: 5–7, 16 May 1992
Katz PO. J Clin Gastroenterol 13 (Suppl. 2): 6–15, 1991
Berg CL, Wolfe MM. Med Clin North Amer 75(4): 903–921, 1991
Misiewicz JJ. Drugs 15: 89–91, 1978
Katz KD, Hollander D. Am J Surg 163: 349–359, 1992
Shinn AF. Drug Safety 7: 245–267, 1992
Grant SM, et al. Drugs 37: 801–870, 1989
Murdoch D, McTavish D. Drugs 42: 240–260, 1991
Arakwa T, et al. J Clin Gastroenterol 13 (Suppl. 1): 129–133, 1991
Barradell LB, et al. Drugs 44: 225–250, 1992
McTavish D, et al. Drugs 42: 138–170, 1991
Licht H, et al. Medecine et Chirurgie Digestives 19: 251–255, 1990
Hatlebakk JG, et al. Abstract. American Gastroenterological Association, May 10–13, 1992
Blum AU. Digestion 47 (Suppl. 1): 3–10, 1990
Scrip No. 1760: 22, 1992
British National Formulary 24: 32–34, 1992
Bate CM, Richardson PDL. Brit J Med Econ 2: 37–48, 1992
Rights and permissions
About this article
Cite this article
Lansoprazole and Omeprazole Challenge H2-Receptor Antagonists in Acid-Related Disorders. Drugs Ther. Perspect 1, 1–4 (1993). https://doi.org/10.2165/00042310-199301020-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199301020-00001